Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT03150511

Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury

Led by Johns Hopkins University · Updated on 2025-11-12

36

Participants Needed

1

Research Sites

495 weeks

Total Duration

On this page

Sponsors

J

Johns Hopkins University

Lead Sponsor

U

United States Department of Defense

Collaborating Sponsor

AI-Summary

What this Trial Is About

The aim of this clinical trial is to evaluate the efficacy of tesamorelin as a therapy for peripheral nerve injuries. The investigators hypothesize that treatment with tesamorelin will result in faster and more substantial recovery of motor and sensory function following surgical repair of injured peripheral nerves. Patients with upper extremity nerve injuries will be randomly assigned to receive either tesamorelin treatment or no treatment. Assessments for nerve regeneration, muscle function, and sensation will be conducted every three months for a total of 12 months. Outcomes in patients receiving tesamorelin will be compared to those in the untreated group to determine the effectiveness of tesamorelin as a therapeutic intervention for nerve injuries.

CONDITIONS

Official Title

Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Ulnar nerve laceration at the wrist that has been repaired primarily
Not Eligible

You will not qualify if you...

  • Active or past certain cancers
  • Uncontrolled diabetes or hypertension
  • Certain pituitary disorders
  • Use of oral contraceptives
  • Pregnancy
  • Drug or alcohol dependence
  • Psychosocial issues that would limit participation and compliance

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Sami Tuffaha

Baltimore, Maryland, United States, 21205

Actively Recruiting

Loading map...

Research Team

S

Sami Tuffaha, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here